WC Bioscience Accelerator Participants

FREZENT Biological Solutions
Affiliations
Icahn School of Medicine at Mount Sinai
Technologies
Therapeutic
Indication
Biomedicine
Molecular Diagnostic
Executive Summary
View/DownloadWebsite
www.frezent.comNatasha Shtraizent
FREZENT Biological Solutions will improve the clinical outcomes in head and neck cancer by developing a novel adjuvant therapeutic, targeting drug-resistant dormant cancer cells.